Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000210510> ?p ?o ?g. }
- W2000210510 endingPage "544" @default.
- W2000210510 startingPage "536" @default.
- W2000210510 abstract "Background: Thalidomide (α-N-phthalimidoglutarimide) is attracting new attention because of its antiangiogenic effect in corneal neovascularization models. However, the effect of this agent on esophageal carcinoma is yet to be established. Methods: The human esophageal squamous cell carcinoma strains ES63 and ES80 implanted subcutaneously in nude mice were used to evaluate the antiangiogenic effect of thalidomide (200 mg/kg/d) after daily gavage or intraperitoneal administration. Tumor size was measured, and assessment of microvessel density was performed histochemically with Griffonia simplicifolia lectin I. Characterizations of angiogenic growth factors, vascular endothelial growth factor, basic fibroblast growth factor, and thymidine phosphorylase in ES63 and ES80 tumors were done by immunohistochemical staining and reverse transcription–polymerase chain reaction. Results: ES63 strongly expressed 3 angiogenic factors, but ES80 showed moderate expression of thymidine phosphorylase and only weak or no expression of vascular endothelial grown factor and basic fibroblast growth factor at protein and messenger RNA levels. In ES63 intraperitoneal injection of thalidomide produced significant (P < .05) inhibition of tumor growth, but there was no effect after gastric gavage. Also, a significantly (P < .0005) lower microvessel density was encountered in the intraperitoneal thalidomide group. However, in the ES80 tumor strain thalidomide had no antiangiogenic effect after either intraperitoneal or oral administration. Conclusions: These data indicate that thalidomide exerts an antiangiogenic effect on solid tumor after intraperitoneal administration. Thalidomide might be one of the hopeful antiangiogenic drugs for solid tumors. (Surgery 1999;125:536-44.)" @default.
- W2000210510 created "2016-06-24" @default.
- W2000210510 creator A5002791969 @default.
- W2000210510 creator A5030048967 @default.
- W2000210510 creator A5034419644 @default.
- W2000210510 creator A5042986871 @default.
- W2000210510 creator A5045920499 @default.
- W2000210510 creator A5048027547 @default.
- W2000210510 creator A5062704912 @default.
- W2000210510 creator A5064345727 @default.
- W2000210510 date "1999-05-01" @default.
- W2000210510 modified "2023-10-14" @default.
- W2000210510 title "Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice" @default.
- W2000210510 cites W1579297325 @default.
- W2000210510 cites W1586662940 @default.
- W2000210510 cites W1963774501 @default.
- W2000210510 cites W1970673746 @default.
- W2000210510 cites W1974520996 @default.
- W2000210510 cites W1977071537 @default.
- W2000210510 cites W1981648195 @default.
- W2000210510 cites W1985147506 @default.
- W2000210510 cites W1985804036 @default.
- W2000210510 cites W1994743159 @default.
- W2000210510 cites W2012390831 @default.
- W2000210510 cites W2018803923 @default.
- W2000210510 cites W2025860500 @default.
- W2000210510 cites W2026338689 @default.
- W2000210510 cites W2039667318 @default.
- W2000210510 cites W2065573720 @default.
- W2000210510 cites W2075017432 @default.
- W2000210510 cites W2078137009 @default.
- W2000210510 cites W2082532236 @default.
- W2000210510 cites W2102848808 @default.
- W2000210510 cites W2121465316 @default.
- W2000210510 cites W2151967532 @default.
- W2000210510 cites W2162559503 @default.
- W2000210510 cites W2319962899 @default.
- W2000210510 cites W2336461395 @default.
- W2000210510 cites W2339981418 @default.
- W2000210510 cites W3022361853 @default.
- W2000210510 doi "https://doi.org/10.1016/s0039-6060(99)70206-0" @default.
- W2000210510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10330943" @default.
- W2000210510 hasPublicationYear "1999" @default.
- W2000210510 type Work @default.
- W2000210510 sameAs 2000210510 @default.
- W2000210510 citedByCount "59" @default.
- W2000210510 countsByYear W20002105102012 @default.
- W2000210510 countsByYear W20002105102013 @default.
- W2000210510 countsByYear W20002105102014 @default.
- W2000210510 countsByYear W20002105102015 @default.
- W2000210510 countsByYear W20002105102020 @default.
- W2000210510 crossrefType "journal-article" @default.
- W2000210510 hasAuthorship W2000210510A5002791969 @default.
- W2000210510 hasAuthorship W2000210510A5030048967 @default.
- W2000210510 hasAuthorship W2000210510A5034419644 @default.
- W2000210510 hasAuthorship W2000210510A5042986871 @default.
- W2000210510 hasAuthorship W2000210510A5045920499 @default.
- W2000210510 hasAuthorship W2000210510A5048027547 @default.
- W2000210510 hasAuthorship W2000210510A5062704912 @default.
- W2000210510 hasAuthorship W2000210510A5064345727 @default.
- W2000210510 hasConcept C121608353 @default.
- W2000210510 hasConcept C126322002 @default.
- W2000210510 hasConcept C134018914 @default.
- W2000210510 hasConcept C142724271 @default.
- W2000210510 hasConcept C167734588 @default.
- W2000210510 hasConcept C170493617 @default.
- W2000210510 hasConcept C2775960820 @default.
- W2000210510 hasConcept C2776364478 @default.
- W2000210510 hasConcept C2776735402 @default.
- W2000210510 hasConcept C2777025900 @default.
- W2000210510 hasConcept C2777587049 @default.
- W2000210510 hasConcept C2778271429 @default.
- W2000210510 hasConcept C2779609412 @default.
- W2000210510 hasConcept C2780159080 @default.
- W2000210510 hasConcept C2780394083 @default.
- W2000210510 hasConcept C71924100 @default.
- W2000210510 hasConcept C98274493 @default.
- W2000210510 hasConceptScore W2000210510C121608353 @default.
- W2000210510 hasConceptScore W2000210510C126322002 @default.
- W2000210510 hasConceptScore W2000210510C134018914 @default.
- W2000210510 hasConceptScore W2000210510C142724271 @default.
- W2000210510 hasConceptScore W2000210510C167734588 @default.
- W2000210510 hasConceptScore W2000210510C170493617 @default.
- W2000210510 hasConceptScore W2000210510C2775960820 @default.
- W2000210510 hasConceptScore W2000210510C2776364478 @default.
- W2000210510 hasConceptScore W2000210510C2776735402 @default.
- W2000210510 hasConceptScore W2000210510C2777025900 @default.
- W2000210510 hasConceptScore W2000210510C2777587049 @default.
- W2000210510 hasConceptScore W2000210510C2778271429 @default.
- W2000210510 hasConceptScore W2000210510C2779609412 @default.
- W2000210510 hasConceptScore W2000210510C2780159080 @default.
- W2000210510 hasConceptScore W2000210510C2780394083 @default.
- W2000210510 hasConceptScore W2000210510C71924100 @default.
- W2000210510 hasConceptScore W2000210510C98274493 @default.
- W2000210510 hasIssue "5" @default.
- W2000210510 hasLocation W20002105101 @default.
- W2000210510 hasLocation W20002105102 @default.
- W2000210510 hasOpenAccess W2000210510 @default.